Cc1ccc(NC(=O)C2(NC(=O)c3cccc(N4C(=O)CSC4c4ccccc4)c3)CCCCC2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?